Benoit Xhonneux

400 total citations
19 papers, 331 citations indexed

About

Benoit Xhonneux is a scholar working on Molecular Biology, Pharmacology and Immunology. According to data from OpenAlex, Benoit Xhonneux has authored 19 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Pharmacology and 5 papers in Immunology. Recurrent topics in Benoit Xhonneux's work include Receptor Mechanisms and Signaling (5 papers), Mast cells and histamine (4 papers) and Analytical Methods in Pharmaceuticals (4 papers). Benoit Xhonneux is often cited by papers focused on Receptor Mechanisms and Signaling (5 papers), Mast cells and histamine (4 papers) and Analytical Methods in Pharmaceuticals (4 papers). Benoit Xhonneux collaborates with scholars based in Belgium. Benoit Xhonneux's co-authors include Fred De Clerck, Paul A. J. Janssen, J.E. Leysen, Thomas Jansen, M. Borgers, Μ. Borgers, Didier de Chaffoy de Courcelles, Josée E. Leysen, J. Van Cutsem and Yves Somers and has published in prestigious journals such as Biochemical Pharmacology, Journal of Antimicrobial Chemotherapy and Thrombosis and Haemostasis.

In The Last Decade

Benoit Xhonneux

19 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benoit Xhonneux Belgium 10 103 72 69 63 48 19 331
Monique Schmitt Switzerland 11 109 1.1× 59 0.8× 74 1.1× 31 0.5× 14 0.3× 23 607
Brody Tm United States 10 239 2.3× 60 0.8× 71 1.0× 62 1.0× 32 0.7× 15 510
Ken Nagashima Japan 12 148 1.4× 47 0.7× 27 0.4× 69 1.1× 24 0.5× 18 369
M J Daly United Kingdom 14 209 2.0× 116 1.6× 77 1.1× 33 0.5× 18 0.4× 30 524
Tillement Jp France 11 118 1.1× 37 0.5× 66 1.0× 19 0.3× 14 0.3× 72 381
E. Bojesen Denmark 11 172 1.7× 38 0.5× 34 0.5× 28 0.4× 86 1.8× 20 483
William Warner United States 13 158 1.5× 90 1.3× 63 0.9× 73 1.2× 66 1.4× 38 447
Masahiro Inagaki Japan 13 109 1.1× 79 1.1× 48 0.7× 39 0.6× 91 1.9× 63 525
Akima Miyoshi Japan 12 120 1.2× 112 1.6× 26 0.4× 13 0.2× 31 0.6× 47 473
R. G. Spector United Kingdom 12 117 1.1× 56 0.8× 61 0.9× 36 0.6× 18 0.4× 56 398

Countries citing papers authored by Benoit Xhonneux

Since Specialization
Citations

This map shows the geographic impact of Benoit Xhonneux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benoit Xhonneux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benoit Xhonneux more than expected).

Fields of papers citing papers by Benoit Xhonneux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benoit Xhonneux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benoit Xhonneux. The network helps show where Benoit Xhonneux may publish in the future.

Co-authorship network of co-authors of Benoit Xhonneux

This figure shows the co-authorship network connecting the top 25 collaborators of Benoit Xhonneux. A scholar is included among the top collaborators of Benoit Xhonneux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benoit Xhonneux. Benoit Xhonneux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Borgers, Μ., Benoit Xhonneux, & J. Van Cutsem. (1993). Oral itraconazole versus topical bifonazole treatment in experimental dermatophytosis. Mycoses. 36(3-4). 105–115. 18 indexed citations
2.
Borgers, Μ., Benoit Xhonneux, & J. Van Cutsem. (1993). Azole‐derivatives in experimental dermatophytoses: oral vs. topical treatment. Journal of the European Academy of Dermatology and Venereology. 2(1). 1–3. 2 indexed citations
3.
Xhonneux, Benoit, et al.. (1992). Effects of itraconazole on phagocytosis and killing of Candida glabrata by polymorphonuclear leucocytes from guinea pigs. Journal of Antimicrobial Chemotherapy. 30(2). 181–188. 7 indexed citations
4.
Borgers, Μ., et al.. (1991). The effects of saperconazole on the morphology of Candida albicans, Pityrosporum ovale and Trichophyton rubrum in vitro.. PubMed. 29(5). 293–303. 7 indexed citations
5.
Borgers, Μ., et al.. (1991). The effects of saperconazole on the morphology ofCandida albicans, Pityrosporum ovaleandTrichophyton rubrum in vitro. Medical Mycology. 29(5). 293–303. 4 indexed citations
6.
Jansen, Thomas, et al.. (1990). Beta-cyclodextrins as vehicles in eye-drop formulations: an evaluation of their effects on rabbit corneal epithelium.. PubMed. 7(3-4). 459–68. 55 indexed citations
7.
Clerck, Fred De, Benoit Xhonneux, & Didier de Chaffoy de Courcelles. (1988). Functional Expression of the Amplification Reaction Between Serotonin and Epinephrine on Platelets. Journal of Cardiovascular Pharmacology. 11. S1–S5. 22 indexed citations
8.
Clerck, Fred De, Benoit Xhonneux, & Didier de Chaffoy de Courcelles. (1988). Functional Expression of the Amplification Reaction Between Serotonin and Epinephrine on Platelets. Journal of Cardiovascular Pharmacology. 11(Sup 1). S1–S5. 6 indexed citations
9.
Clerck, Fred De, Benoit Xhonneux, Yves Somers, et al.. (1987). PLATELET TXA2 SYNTHETASE INHIBITION AND TXA2/PROSTAGLANDIN ENDOPEROXIDE RECEPTOR BLOCKADE COMBINED IN ONE MOLECULE (R 68070). Thrombosis and Haemostasis. 2 indexed citations
10.
Clerck, Fred De & Benoit Xhonneux. (1986). Effects of ketanserin, a selective 5-HT2 serotonergic antagonist, on the secondary recruitment of human plateletsin vitro. Inflammation Research. 17(5-6). 515–526. 15 indexed citations
11.
Vermylen, J., Jef Arnout, Hans Deckmyn, Benoit Xhonneux, & Fred De Clerck. (1986). Continuous inhibition of the platelet S2-serotonergic receptors during the long term administration of ketanserin. Thrombosis Research. 42(5). 721–723. 5 indexed citations
13.
Clerck, Fred De, et al.. (1985). Biochemical mechanisms in 5-hydroxytryptamine-induced human platelet aggregation. Inflammation Research. 17(2). 220–228. 10 indexed citations
14.
Clerck, Fred De, Benoit Xhonneux, J.P. Tollenaere, & Paul A. J. Janssen. (1985). Dependence of the antagonism at human platelet 5-HT2 receptors by ketanserin on the reaction pH. Thrombosis Research. 40(5). 581–596. 7 indexed citations
15.
Clerck, Fred De & Benoit Xhonneux. (1985). Continuous Inhibition of Platelet S2-Serotonergic Receptors During Chronic Administration of Ketanserin in Humans. Journal of Cardiovascular Pharmacology. 7. 23–25. 16 indexed citations
16.
Clerck, Fred De, Benoit Xhonneux, J.E. Leysen, & Paul A. J. Janssen. (1984). Evidence for functional 5-HT2 receptor sites on human blood platelets. Biochemical Pharmacology. 33(17). 2807–2811. 84 indexed citations
17.
Clerck, Fred De, Benoit Xhonneux, Josée E. Leysen, & Paul A. J. Janssen. (1984). The involvement of 5-HT2-receptor sites in the activation of cat platelets. Thrombosis Research. 33(3). 305–321. 37 indexed citations
18.
Clerck, Fred De, et al.. (1983). Platelet activation by endogenous 5-hydroxytryptamine and histamine released by mast cell degranulation with compound 48/80 in the rat. Inflammation Research. 13(1). 81–87. 11 indexed citations
19.
Clerck, Fred De, et al.. (1982). Enhanced platelet turnover and prostaglandin production in spontaneously hypertensive rats. Thrombosis Research. 27(3). 243–249. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026